Physician profile
Maury Harris
NPI 1205999810
$961.64
in general payments reported to CMS, 2019-2025
19 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.46 · 2020: $365 · 2021: $26.82 · 2022: $30.06 · 2023: $40.46 · 2024: $281 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $159.88 | 2020-2024 | Xiaflex |
| Horizon Therapeutics Plc | $152.04 | 2020-2022 | |
| Djo, LLC | $151.01 | 2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $63.97 | 2024-2025 | |
| Endo USA, INC. | $48.74 | 2025 | Xiaflex |
| Depuy Synthes Sales INC. | $48.07 | 2021-2024 | Orthovisc |
| Orthofix Medical, INC. | $40.80 | 2019 | |
| Exact Sciences Corporation | $39.90 | 2023-2024 | Cologuard Collection Kit |
| Integra Lifesciences Corporation | $38.05 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Eisai INC. | $28.35 | 2025 | |
| Janssen Biotech, INC. | $28.11 | 2020 | |
| Lundbeck LLC | $24.24 | 2024 | Rexulti |
| Incyte Corporation | $22.74 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $22.68 | 2023 | Rexulti |
| Shield Therapeutics INC | $21.17 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $20.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.55 | 2020 | |
| Puma Biotechnology, INC. | $16.37 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maury Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.